Mindset Pharma Next Generation Psychedelics

Media Summary: We had the pleasure of speaking with James Lanthier, CEO of On this Investors Coliseum Featured Company Halftime Report we will be hearing from James Lanthier CEO of Mindeset Episode 5 - June 10th 2020 James Lanthier - CEO at

Mindset Pharma Next Generation Psychedelics - Detailed Analysis & Overview

We had the pleasure of speaking with James Lanthier, CEO of On this Investors Coliseum Featured Company Halftime Report we will be hearing from James Lanthier CEO of Mindeset Episode 5 - June 10th 2020 James Lanthier - CEO at We reconnected with James Lanthier, CEO of In this episode of the podcast, Joe Moore interviews the CEO of

Photo Gallery

Mindset Pharma, Next Generation Psychedelics

Management of Mindset Pharma Educates us on the Basics of Psychedelic Patents!!!

Can Next Generation Psychedelics Treat Mental Illness? | Mindset Pharma | DMT, 5-MEO-DMT

Mindset Pharma: Leaders in Next-Gen Psychedelics

Mindset Pharma Halftime Report 2022

Mindset Pharma Half-Time Report with CEO James Lanthier

Mindset Pharma discusses decision to expand into non-hallucinogenic drug discovery

Mindset Pharma develops rodent studies to differentiate between psychedelic and non-psychedelics

Mindset Pharma Gains New Insights In Psychedelics | CEO James Lanthier and CSO Joe Araujo

Mindset gets Groundbreaking Psychedelics Endorsement from Big Pharma

The Future of Psychedelic Medicines with Mindset Pharma

What Is A 2nd Generation Psychedelic? | Mindset Pharma

View Detailed Profile

Mindset Pharma, Next Generation Psychedelics

Mindset Pharma, Next Generation Psychedelics

James Lanthier CEO of

Management of Mindset Pharma Educates us on the Basics of Psychedelic Patents!!!

Management of Mindset Pharma Educates us on the Basics of Psychedelic Patents!!!

Mindset Pharma

Can Next Generation Psychedelics Treat Mental Illness? | Mindset Pharma | DMT, 5-MEO-DMT

Can Next Generation Psychedelics Treat Mental Illness? | Mindset Pharma | DMT, 5-MEO-DMT

In today's episode of the

Mindset Pharma: Leaders in Next-Gen Psychedelics

Mindset Pharma: Leaders in Next-Gen Psychedelics

We had the pleasure of speaking with James Lanthier, CEO of

Mindset Pharma Halftime Report 2022

Mindset Pharma Halftime Report 2022

Patents, Partnerships,

Mindset Pharma Half-Time Report with CEO James Lanthier

Mindset Pharma Half-Time Report with CEO James Lanthier

On this Investors Coliseum Featured Company Halftime Report we will be hearing from James Lanthier CEO of Mindeset

Mindset Pharma discusses decision to expand into non-hallucinogenic drug discovery

Mindset Pharma discusses decision to expand into non-hallucinogenic drug discovery

Mindset Pharma

Mindset Pharma develops rodent studies to differentiate between psychedelic and non-psychedelics

Mindset Pharma develops rodent studies to differentiate between psychedelic and non-psychedelics

Mindset Pharma

Mindset Pharma Gains New Insights In Psychedelics | CEO James Lanthier and CSO Joe Araujo

Mindset Pharma Gains New Insights In Psychedelics | CEO James Lanthier and CSO Joe Araujo

Mindset Pharma

Mindset gets Groundbreaking Psychedelics Endorsement from Big Pharma

Mindset gets Groundbreaking Psychedelics Endorsement from Big Pharma

James Lanthier, CEO of

The Future of Psychedelic Medicines with Mindset Pharma

The Future of Psychedelic Medicines with Mindset Pharma

There's been much excitement in the

What Is A 2nd Generation Psychedelic? | Mindset Pharma

What Is A 2nd Generation Psychedelic? | Mindset Pharma

Mindset Pharma

Organic v. Synthetic Psychedelics: Brom w/ James Lanthier, CEO Mindset Pharma | PsyCap Sep '21

Organic v. Synthetic Psychedelics: Brom w/ James Lanthier, CEO Mindset Pharma | PsyCap Sep '21

Brom the

Psychedelic Insiders #005 - James Lanthier, CEO of Mindset Pharma

Psychedelic Insiders #005 - James Lanthier, CEO of Mindset Pharma

Episode 5 - June 10th 2020 James Lanthier - CEO at

Mindset Pharma (MSET): The Next Generation of Intellectual Property in the Psychedelics

Mindset Pharma (MSET): The Next Generation of Intellectual Property in the Psychedelics

We reconnected with James Lanthier, CEO of

Psychedelic Company Partnering With CAMH | Mindset Pharma

Psychedelic Company Partnering With CAMH | Mindset Pharma

Mindset Pharma

PT332 – James Lanthier – Patentability, Capitalism, and The Next Generation of Psychedelics

PT332 – James Lanthier – Patentability, Capitalism, and The Next Generation of Psychedelics

In this episode of the podcast, Joe Moore interviews the CEO of

Corporate Overview of Mindset Pharma Inc. from James Lanthier- CEO

Corporate Overview of Mindset Pharma Inc. from James Lanthier- CEO

Mindset Pharma

Mindset Pharma shares positive preclinical results on its two sets of psychedelic drug families

Mindset Pharma shares positive preclinical results on its two sets of psychedelic drug families

Mindset Pharma

Related Video Content

What Mindset Is and Why It Matters - Verywell Mind information

2 days ago · Learn why your mindset plays a major role in both motivation and achievement, plus discover whether you...

Mindset - Wikipedia information

Numerous scholars have identified mindset history as being a critical gap in contemporary literature and also in...

17 Types Of Mindsets: What's Yours - Growth Tactics information

Jun 11, 2025 · Mindset can have a huge impact on your success and happiness. Learn these 17 types of mindsets to...

MINDSET Definition & Meaning - Merriam-Webster information

6 days ago · The meaning of MINDSET is a mental attitude or inclination. How to use mindset in a sentence.

What is a Mindset? information

Feb 20, 2026 · So let’s cut through the noise and talk about what mindset actually is, why it matters so much, and...